Patients in cardiogenic shock refractory to basic medical therapy may require specialised assistance in a multispeciality environment distant to the institution where they are first admitted. In such situations, transportation of these critical patients may be difficult and involve many risks. Here we describe the case histories of two patients who underwent implantation of a paracorporeal left ventricular assist device and were transferred to specialised institutions for extended treatment. The distance of transportation was 400 km and the patients were transported by ambulance and helicopter. Some aspects of logistics and complexity of long-distance transportation are also commented on.
MooneyM.R., AromK.V., JoyceL.D.Emergency cardiopulmonary bypass support in patients with cardiac arrest. J Thorac Cardiovasc Surg1991; 101: 450–4.
2.
DuarteJ., Fernández-CaleyaD., Alvarez-ValdivielsoJ.M.First clinical implantation of the BCM 3.5 ventricular assist device (VAD). Eur J Cardiothorac Surg1991; 5: 46–50.
3.
DuarteJ., Fernández-CaleyaD., Alvarez-ValdivielsoJ.M.Uso clínico del sistema BCM como puente al transplante. Clin Cardiovasc1993; 11: 41–50.
4.
Del CañizoJ.F., AntoranzJ.C., DescoM.M.Development and clinical assay of the BCM ventricular assist device. Int J Artif Organs1994; 18: 484–9.
5.
NewsomeL.R., PonganisP., ReichmanR.Portable percutaneous cardiopulmonary bypass: Use in supported coronary angioplasty, aortic valvuloplasty and cardiac arrest. J Cardiothorac Vasc Anesth1992; 6: 328–31.
6.
El-BanayosyA., PosivalH., HartmannD.Transport of patients in cardiogenic shock with mobile femoral-femoral cardiopulmonary bypass. J Cardiothorac Vasc Anesth1995; 3: 301–3.
7.
HotvedtR., KristiansenI.S., FordeO.H.Which groups of patients benefit from helicopter evacuation. Lancet1996; 347: 1362–6.
8.
GilliganJ.E., GoonP., MaughanG., GriggsW., HaslamR., ScholtenA.. An airborne intensive care facility (fixed wing). Anaesth Intensive Care (Australia)1996; 24: 245–53.
